CytoSciences

CytoSciences was a medical technology company focused on the early detection of lung cancer through non-invasive diagnostic solutions. The company developed the AeroTest, a proprietary system designed for the collection and cytological analysis of sputum to identify malignant cells in the lungs. By targeting high-risk populations, CytoSciences aimed to provide a cost-effective and accessible screening tool that could complement traditional imaging techniques. The technology was intended to improve patient survival rates by facilitating diagnosis at earlier, more treatable stages of the disease. Although the company is no longer active, its work represented a significant effort in the field of respiratory oncology diagnostics.